Brought to you by 
Interlace Medical raises $20.5mm through its Series C round
13 Oct 2011
Executive Summary
Interlace Medical (gynecological devices) has raised $20.5mm through its Series C venture round. Baird Venture Partners and HLM Venture Partners led the financing and were joined by fellow new investors H&Q Capital Management and Aperture Venture Partners, and current backers New Leaf Venture Partners and Spray Venture Partners. Representatives from Baird and HLM will take seats on the company's board. Interlace will use the proceeds to market its MyoSure minimally invasive device for uterine fibroids and polyps.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Interlace Medical raises $20.5mm through its Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice